Melissa Cushing, MD

Daniel M. Knowles, MD Distinguished Professor in Pathology and Laboratory Medicine

Contact & profiles

Appointments

Professor of Pathology and Laboratory MedicinePrimary
Pathology and Laboratory Medicine · 2019–
Daniel M. Knowles, MD Distinguished Professor in Pathology and Laboratory Medicine
Pathology and Laboratory Medicine · 2022–
Professor of Pathology and Laboratory Medicine in Anesthesiology
Anesthesiology · 2019–
Physician
NewYork-Presbyterian Hospital

Past Appointments

Associate Professor of Pathology & Laboratory Medicine in Clinical Anesthesiology
Anesthesiology · 2015–2018
Associate Professor of Clinical Pathology and Laboratory Medicine
Pathology and Laboratory Medicine · 2013–2018
Assistant Professor of Clinical Pathology and Laboratory Medicine
Pathology and Laboratory Medicine · 2013–2013

Show all 4

Assistant Professor of Pathology and Laboratory Medicine
Pathology and Laboratory Medicine · 2006–2013

Centers

Education

Highlights

1
Transfusion · 2020
RDRobert DeSimone GEGrant Ellsworth RMRoy M Gulick MCMelissa Cushing
PMID: 33215718PMCID: PMC7753518DOISenior author23 citations
2
American journal of clinical pathology · 2022
DPDavid P. Calfee HKHarjot Kaur Singh LFLars F Westblade MCMelissa Cushing
PMID: 35648100PMCID: PMC9213858DOISenior author5 citations
3
Transfusion · 2021
MCMelissa Cushing
PMID: 33629748DOISenior author9 citations

163

Completed grants (5)

Co-I
The New York Comprehensive Thalassemia Center - Expanded Network
Centers for Disease Control and Prevention · 2019–2025
No publications yet
NU58DD000005-01 00
Sub-PI
Recipient Epidemiology and Donor Evaluation Study IV - Pediatric (REDS-IV-P} -Domestic Hubs - Phase 3
National Heart, Lung, and Blood Institute · 2024–2025 · via Columbia University
75N92019D00037
Sub-PI
Recipient Epidemiology and Donor Evaluation Study IV - Pediatric (REDS-IV-P} -Domestic Hubs - Phase 2 Budget B
National Heart, Lung, and Blood Institute · 2021–2024 · via Columbia University
75N92019D00037
Sub-PI
Recipient Epidemiology and Donor Evaluation Study IV - Pediatric (REDS-IV-P} -Domestic Hubs - Phase 2 Budget B
National Heart, Lung, and Blood Institute · 2021–2024 · via Columbia University
75N92019D00037
Sub-PI
REDS-IV-P Domestic Hubs
National Heart, Lung, and Blood Institute · 2019–2022 · via Columbia University
75N92019D00037

2 studies

PI
Recipient Epidemiology and Donor Evaluation Study-IV-Pediatric (REDS-IV-P) Vein-to-Vein (V2V) Database
National Heart, Lung, & Blood Institute · OPEN TO ACCRUAL (as of 2020)
PI
Laboratory analysis of clinical samples and data analysis of clinical test results and patient data of novel coronavirus 19 (COVID-19)
Weill Medical College of Cornell University · OPEN TO ACCRUAL (as of 2020)

Completed & closed trials (4)

PI
Red Blood Cell - IMProving trAnsfusions for Chronically Transfused Recipients (RBC-IMPACT)
National Heart, Lung, & Blood Institute · IRB STUDY CLOSURE (as of 2025)
Sickle Cell Disease; Thalassemia; Pediatric Cancer
NCT05255445
PI
Pilot Clinical Trial of Transfusion of Pathogen Reduced Cryoprecipitated Fibrinogen (INTERCEPT Fibrinogen Complex) in Patients With Bleeding to Expedite Product Availability and Improve Outcomes in Perioperative Bleeding
PHASE4 · Weill Medical College of Cornell University · CLOSED TO ACCRUAL (as of 2024)
Hypofibrinogenemia; Bleeding
NCT05711524
PI
A Utilization Review Method Using a Visual Analytics Dashboard for SARS-CoV-2 Diagnostic Tests at a Large Urban Hospital
New York Presbyterian Hospital · IRB STUDY CLOSURE (as of 2023)
PI
Potential of Non-COVID19 Coronavirus Cross-reactivity in COVID19 Serological Testing
Weill Medical College of Cornell University · IRB STUDY CLOSURE (as of 2021)

Gut Fungi's Lasting Impact on Severe COVID-19 Immune Response
October 23, 2023
Certain gut-dwelling fungi flourish in severe cases of COVID-19, amplifying the excessive inflammation that drives this disease while also causing long-lasting changes in the immune system, according to a new study led by investigators at Weill Cornell Medicine and NewYork-Presbyterian.